Liposomal Nitrooxy-Doxorubicin: One Step over Caelyx in Drug-Resistant Human Cancer Cells
Author:
Affiliation:
1. Department of Drug Science and Technology, University of Torino, via Pietro Giuria 9, 10125 Torino, Italy
2. Department of Oncology, University of Torino, via Santena 5/bis, 10126 Torino, Italy
Funder
Italian Association for Cancer Research
Italian Ministry of University and Research
Fondazione Italiana per la Ricerca sul Cancro
Publisher
American Chemical Society (ACS)
Subject
Drug Discovery,Pharmaceutical Science,Molecular Medicine
Link
https://pubs.acs.org/doi/pdf/10.1021/mp500257s
Reference48 articles.
1. Multidrug resistance in cancer: role of ATP–dependent transporters
2. Tyrosine kinase inhibitors as modulators of ATP binding cassette multidrug transporters: substrates, chemosensitizers or inducers of acquired multidrug resistance?
3. Delivery of molecularly targeted therapy to malignant glioma, a disease of the whole brain
4. Targeting MDR in breast and lung cancer: Discriminating its potential importance from the failure of drug resistance reversal studies
5. Drug resistance: Still a daunting challenge to the successful treatment of AML
Cited by 29 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Multi drug resistance in Colorectal Cancer- approaches to overcome, advancements and future success;Advances in Cancer Biology - Metastasis;2024-07
2. Multidrug Resistance in Cancer: Understanding Molecular Mechanisms, Immunoprevention and Therapeutic Approaches;Frontiers in Oncology;2022-06-23
3. Progress in nanotechnology-based targeted cancer treatment;Photophysics and Nanophysics in Therapeutics;2022
4. Nanomedicine to Overcome Multidrug Resistance Mechanisms in Colon and Pancreatic Cancer: Recent Progress;Cancers;2021-04-24
5. Nanomedicine for Gene Delivery and Drug Repurposing in the Treatment of Muscular Dystrophies;Pharmaceutics;2021-02-19
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3